Table 2 Patient characteristics on romiplostim.
From: Platelet function and bleeding at different phases of childhood immune thrombocytopenia
Characteristic | |
|---|---|
Number | 22 |
Gender | |
Girls, n = | 12 |
Boys, n = | 10 |
Age, median (range) | 10 (2–16) |
Platelet count, × 109/L, median (range) | 94 (9–327) |
Prior therapy | |
Steroids, n = | 22 |
IVIG, n = | 20 |
Rituximab, n = | 3 |
IFN alpha2b, n = | 6 |
Thrombopoietin mimetic, n = | 1 |
Splenectomy, n = | 1 |
